Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥2.24T2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥4.39T2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.15T2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥136.7bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥138.6bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥106.1bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax¥240.5bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥130.2bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥40.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥119.6bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥67.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥71.2bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income¥178.4bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥94.1bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥5.95Tat 2024-09-30Cons.Assets IFRS
Total assets¥6.10Tat 2024-03-31Cons.Assets IFRS
Total assets¥6.12Tat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.69Tat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥3.83Tat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥2.26Tat 2024-09-30Cons.Equity IFRS
Net assets / equity¥2.28Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥2.21Tat 2023-09-30Cons.Equity IFRS
Net assets / equity¥1.99Tat 2023-03-31dCons.Equity IFRS
Equity (owners)¥1.74Tat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.76Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.72Tat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥297.5bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥294.9bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥398.8bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥297.2bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥275.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥465.1bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥195.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥145.3bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥246.1bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥115.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥124.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥241.7bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥6.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥28.762024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥84.072023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥47.252023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥28.742024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥80.772023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥45.222023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio29.2%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.9%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.2%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥149.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥78.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥70.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥4.3bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥106.6bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥106.6bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥5.1bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue2024-04-01 → 2024-09-30¥539.3bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue external2024-04-01 → 2024-09-30¥521.1bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥18.2bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentsegment profit2024-04-01 → 2024-09-30−¥10.5bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2024-04-01 → 2024-09-30¥643.0bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2024-04-01 → 2024-09-30¥639.4bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥3.6bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2024-04-01 → 2024-09-30¥91.9bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue2024-04-01 → 2024-09-30¥235.9bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue external2024-04-01 → 2024-09-30¥227.4bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥8.5bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentsegment profit2024-04-01 → 2024-09-30¥25.9bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue2024-04-01 → 2024-09-30¥232.6bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue external2024-04-01 → 2024-09-30¥232.5bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥50m
jpcrp040300-q2r_E00808-000Pharmareportable segmentsegment profit2024-04-01 → 2024-09-30¥41.4bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue2024-04-01 → 2024-09-30¥548.1bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue external2024-04-01 → 2024-09-30¥542.7bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥5.4bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentsegment profit2024-04-01 → 2024-09-30¥24.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥165.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥92.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥73.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥6.1bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥108.8bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥108.8bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥5.5bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue2023-04-01 → 2023-09-30¥548.3bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue external2023-04-01 → 2023-09-30¥528.7bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥19.6bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentsegment profit2023-04-01 → 2023-09-30−¥14.6bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2023-04-01 → 2023-09-30¥612.6bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2023-04-01 → 2023-09-30¥608.2bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥4.3bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2023-04-01 → 2023-09-30¥80.3bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue2023-04-01 → 2023-09-30¥187.4bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue external2023-04-01 → 2023-09-30¥181.2bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥6.1bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentsegment profit2023-04-01 → 2023-09-30¥2.2bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue2023-04-01 → 2023-09-30¥219.4bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue external2023-04-01 → 2023-09-30¥219.3bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥67m
jpcrp040300-q2r_E00808-000Pharmareportable segmentsegment profit2023-04-01 → 2023-09-30¥32.3bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue2023-04-01 → 2023-09-30¥525.7bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue external2023-04-01 → 2023-09-30¥520.2bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥5.5bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentsegment profit2023-04-01 → 2023-09-30¥18.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 887
ItemContextValueUnit
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration-JPY
Total transactions with owners IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-930000000JPY
Total transactions with owners IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember667000000JPY
Total transactions with owners IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Total transactions with owners IFRSCurrentYTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-263000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-22398000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-9259000000JPY
Total transactions with owners IFRSCurrentYTDDuration-31657000000JPY
Equity IFRSCurrentQuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember34447000000JPY
Equity IFRSCurrentQuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember-JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember179077000000JPY
Equity IFRSCurrentQuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember3663000000JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember217187000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember1738849000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember519119000000JPY
Equity IFRSCurrentQuarterInstant2257968000000JPY
Profit loss before tax IFRSPrior1YTDDuration130151000000JPY
Profit loss before tax IFRSCurrentYTDDuration106102000000JPY
Depreciation and amortization ope cf IFRSPrior1YTDDuration135631000000JPY
Depreciation and amortization ope cf IFRSCurrentYTDDuration139192000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration-4213000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration-3085000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration3413000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration30404000000JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSPrior1YTDDuration3795000000JPY
Loss gain on sale and retirement of fixed assets ope cf IFRSCurrentYTDDuration4901000000JPY
Provision for loss on business liquidation ope cf IFRSPrior1YTDDuration467000000JPY
Provision for loss on business liquidation ope cf IFRSCurrentYTDDuration1826000000JPY
Gain on sale of investments in subsidiaries and associates ope cf IFRSPrior1YTDDuration-7351000000JPY
Gain on sale of investments in subsidiaries and associates ope cf IFRSCurrentYTDDuration-11132000000JPY
Loss gain on sale of fixed assets ope cf IFRSPrior1YTDDuration-1097000000JPY
Loss gain on sale of fixed assets ope cf IFRSCurrentYTDDuration-4905000000JPY
Reversal of provision for loss on plant closure ope cf IFRSPrior1YTDDuration-1791000000JPY
Reversal of provision for loss on plant closure ope cf IFRSCurrentYTDDuration-673000000JPY
Gain on reversal of asset retirement obligations ope cf IFRSPrior1YTDDuration-2639000000JPY
Gain on reversal of asset retirement obligations ope cf IFRSCurrentYTDDuration-JPY
Interest and dividend income ope cf IFRSPrior1YTDDuration-7238000000JPY
Interest and dividend income ope cf IFRSCurrentYTDDuration-5055000000JPY
Interest expenses ope cf IFRSPrior1YTDDuration21333000000JPY
Interest expenses ope cf IFRSCurrentYTDDuration22104000000JPY
Decrease increase in trade receivables ope cf IFRSPrior1YTDDuration-518000000JPY
Decrease increase in trade receivables ope cf IFRSCurrentYTDDuration47763000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration344000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-42372000000JPY
Increase decrease in trade payables ope cf IFRSPrior1YTDDuration-6748000000JPY
Increase decrease in trade payables ope cf IFRSCurrentYTDDuration-14472000000JPY
Increase or decrease in retirement benefit asset or liability ope cf IFRSPrior1YTDDuration1873000000JPY
Increase or decrease in retirement benefit asset or liability ope cf IFRSCurrentYTDDuration2390000000JPY
Increase decrease in employees bonus liabilities ope cf IFRSPrior1YTDDuration-22454000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass